Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers
2006

Cerebrovascular Disease and Antiphospholipid Antibodies

Sample size: 45 publication Evidence: moderate

Author Information

Author(s): Carolyn Hawkins, Paul Gatenby, Roger Tuck, Gytis Danta, Colin Andrews

Primary Institution: The Canberra Hospital

Hypothesis

What is the significance of transiently positive antiphospholipid antibodies in patients with cerebrovascular disease?

Conclusion

The study suggests that transiently positive antiphospholipid antibodies may be clinically significant despite the absence of intercurrent risk factors.

Supporting Evidence

  • Neurological syndromes are common in patients with antiphospholipid antibodies.
  • The study identified three subgroups of patients based on antibody testing.
  • Only one patient in the transiently positive group had a potential cause for their symptoms.

Takeaway

Some people with certain antibodies can have strokes, but not everyone with those antibodies will have problems later on.

Methodology

A descriptive analysis of 45 patients with cerebral arterial or venous thrombosis and antiphospholipid antibodies.

Potential Biases

Potential bias due to non-blinded assessment and retrospective data collection.

Limitations

The study is descriptive and open to bias, with no comparative group without antiphospholipid antibodies.

Participant Demographics

Median age was 38.2 years, with 32 females and 13 males.

Digital Object Identifier (DOI)

10.1186/1740-2557-3-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication